Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:30 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 1,165 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Sham-device Clear all

Conditions: Spinal Cord Injury
Interventions: Rehabilitation, Noninvasive brain stimulation: tDCS, Sham tDCS: placebo noninvasive brain stimulation; Behavioral · Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Heart Failure
Interventions: Active reprogam; Device
Lead sponsor: St. Francis Hospital, New York; Other
Eligibility: Not listed
Enrollment: 30 participants
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Roslyn, New York

Conditions: Epigastric Pain Syndrome
Interventions: AutoSTEA device, Sham treatment; Device
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 2
States / cities: Cleveland, Ohio • Parma, Ohio

Conditions: Hypertension, Resistant Hypertension
Interventions: MobiusHD, Sham Implantation; Device · Other
Lead sponsor: Vascular Dynamics, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 5
States / cities: Atlanta, Georgia • Springfield, Illinois • Indianapolis, Indiana + 2 more

Conditions: Cognitive Change
Interventions: Stimulation via noninvasive brain stimulation systems; Other
Lead sponsor: Tufts University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Medford, Massachusetts

Conditions: PostTraumatic Stress Disorder
Interventions: GammaCore/electroCore non-invasive VNS device, Sham gammaCore/electroCore, O-15 water; Device · Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Anxiety
Interventions: CES treatment using Alpha-Stim technology, Shame CES Treatment; Device
Lead sponsor: Wyndhurst Counseling Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 2
States / cities: Lynchburg, Virginia

Conditions: Diabetes Mellitus, Type 2
Interventions: Ultrasound Vagus Nerve Stimulation (DECIMA); Device
Lead sponsor: Aucta Technologies, Inc.; Industry
Eligibility: 21 Years to 60 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Chronic Pain, Opioid Use Disorder
Interventions: RelieVRx, Sham VR; Device
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: PTSD
Interventions: TMS 1 hz, Sham TMS; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 19 Years to 70 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: White River Junction, Vermont

Conditions: Glaucoma, Glaucoma Open-Angle
Interventions: Eyetronic rtACS, Sham rtACS; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Critical Limb Ischemia, Peripheral Arterial Disease, Peripheral Vascular Disease
Interventions: Bone marrow concentration device, Placebo procedure (sham); Device · Procedure
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 21 Years and older
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2020
U.S. locations: 25
States / cities: Little Rock, Arkansas • Sacramento, California • Miami, Florida + 20 more

Conditions: Opioid Use Disorder
Interventions: active tDCS, sham tDCS; Device
Lead sponsor: Butler Hospital; Other
Eligibility: 21 Years to 60 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Chronic Pancreatitis, Recurrent Pancreatitis
Interventions: Gut Directed VR, Sham Control VR; Device
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Breast Cancer Female
Interventions: Bupivacaine Hydrochloride, Placebo Drug, Pulsed Electromagnetic Field (PEMF) Device, Placebo Device, Ropivacaine Hydrochloride; Drug · Other · Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: 8 weeks of home based use.; Device
Lead sponsor: Michigan State University; Other
Eligibility: 8 Years to 17 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: East Lansing, Michigan

Conditions: Bipolar Depression
Interventions: Low Field Magnetic Stimulation; Device
Lead sponsor: Mclean Hospital; Other
Eligibility: 21 Years to 65 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Stroke, Mild Cognitive Impairment
Interventions: Transcranial Dirrect Current Stimulation; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 99 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Frailty
Interventions: Magnetic Mitohormesis Therapy; Other
Lead sponsor: Auburn University; Other
Eligibility: 60 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Stress Response
Interventions: Transcutaneous Vagus Nerve Stimulation (tVNS), Evaluative Stress Task; Device · Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 65 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Spinal Cord Injury, Chronic, Spinal Cord Injury Cervical, Spinal Cord Injury Thoracic, Incomplete Spinal Cord Injury
Interventions: Active Comparator: Single Intervention 1, Active Comparator: Single Intervention 2, Respiratory Resistance Exercise; Other · Behavioral
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Photobiomodulation Therapy, Photomedicine, Low-Level Laser Therapy, Performance Enhancement, Quadriceps, Special Operations Readiness
Interventions: THOR3 training + Photobiomodulation Therapy (PBMT), THOR3 training + sham PBMT; Device
Lead sponsor: Musculoskeletal Injury Rehabilitation Research for Operational Readiness; Federal
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Joint Base Lewis McChord, Washington

Conditions: Spatial Navigation
Interventions: Active 10-Hz TMS to the parietal cortex, Active single pulse TMS to the parietal cortex, Sham 10-Hz TMS to the right parietal cortex, Sham single-pulse rTMS the rigt parietal cortex; Device
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 55 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: PAD - Peripheral Arterial Disease, PVD- Peripheral Vascular Disease
Interventions: Tennant Biomodulator-Pro™ Device; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Redwood City, California

Search by objective public record fields.

Improving Spinal Cord Injury Rehabilitation Interventions by Retraining the Brain With Stimulation

Optimization of Cardiac Pacing Using CardioMEMS

TEA Synchronized With Natural Breathing for EPS

CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™

Altering Multitasking Behavior Using Low Current Brain Stimulation

Closed Loop Vagal Nerve Stimulation for Patients With Posttraumatic Stress Disorder

Use of Alpha-Stim Cranial-electrotherapy Stimulation (CES) in the Treatment of Anxiety

Acute Study of Effect of Ultrasound Vagus Nerve Stimulation on Glycemia

Virtual Reality for Chronic Pain and Opioid Use Disorder Pilot

Transcranial Magnetic Stimulation to Improve Functioning in Veterans With PTSD

Electrical Stimulation for Vision Neuroenhancement in Glaucoma

Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)

tDCS to Decrease Opioid Relapse (UH3)

VR Pilot for Pancreatitis

PEMF and PEC Blocks in Mastectomy Reconstruction Patients

Efficacy of the Apollo System for Children With ADHD

Multiple Treatment Study Using Low Field Magnetic Stimulation for Bipolar Depression

tDCS for Post-Stroke Cognitive Impairment

Pilot-testing the Effect of Magnetic Mitohormesis Therapy for Treating Frailty in Older Adults

Transcutaneous Vagus Nerve Stimulation (tVNS) and Stress Regulation During Performance Tasks

Non-Invasive Interventions for Respiratory Recovery in Chronic Spinal Cord Injury

Photomedicine Project 14: PBMT for Performance Enhancement in SOF

Modulating Goal-directed Navigation Using Noninvasive Brain Stimulation

Electrical Stimulation as an Adjunctive Therapy to Increase Vascular Perfusion in People With PAD or PVD